Xu-Chen Cao

Prof. Xu-Chen Cao


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 March 2018 in Molecular Cancer
Verified
Journal Article
Open access
PDF file
YYYue Yu
Yue Yu
WLWei Luo
Wei Luo
ZYZheng-Jun Yang
Zheng-Jun Yang
JCJiang-Rui Chi
Jiang-Rui Chi
YLYun-Rui Li
Yun-Rui Li
XCXu-Chen Cao
Xu-Chen Cao
Breast cancer is the most common cancer among women worldwide and metastasis is the leading cause of death among patients with breast cancer. The transforming growth factor-β (TGF-β) pathway plays critical roles during breast cancer epithelial–mesenchymal transition (EMT) and metastasis. SMAD2, a positive regulator of TGF-β signaling, promotes breast cancer metastasis through induction of EMT. The expression of miR-190 and SMAD2 in breast cancer tissues, adjacent normal breast tissues and cell lines were determined by RT-qPCR. The protein expression levels and localization were analyzed by western blotting and immunofluorescence. ChIP and dual-luciferase report assays were used to validate the regulation of ZEB1-miR-190-SMAD2 axis. The effect of miR-190 on breast cancer progression was investigated both in vitro and in vivo. miR-190 down-regulation is required for TGF-β-induced EMT. miR-190 suppresses breast cancer metastasis both in vitro and in vivo by targeting SMAD2. miR-190 expression is down-regulated and inversely correlates with SMAD2 in breast cancer samples, and its expression level was associated with outcome in patients with breast cancer. Furthermore, miR-190 is transcriptionally regulated by ZEB1. Our data uncover the ZEB1-miR-190-SMAD2 axis and provide a mechanism to explain the TGF-β network in breast cancer metastasis.

6 January 2020 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
WJWei Ji
Wei Ji
YDYu-Ling Diao
Yu-Ling Diao
YQYi-Ran Qiu
Yi-Ran Qiu
JGJie Ge
Jie Ge
XCXu-Chen Cao
Xu-Chen Cao
YYYue Yu
Yue Yu
Breast cancer is the most common malignant tumor among women worldwide. Although increasing evidence indicates that long noncoding RNAs (lncRNAs) play critical roles during breast tumorigenesis and progression, the involvement of most lncRNAs in breast cancer remains largely unknown. In the current study, we demonstrated that LINC00665 promotes breast cancer cell proliferation, migration, and invasion. Accumulating evidence indicates that many lncRNAs can function as endogenous miRNA sponges by competitively binding common miRNAs. In this study, we demonstrated that LINC00665 functions as a sponge for miR-379-5p, reducing the ability of miR-379-5p to repress LIN28B. LINC00665 promoted breast cancer progression and induced an epithelial–mesenchymal transition-like phenotype via the upregulation of LIN28B expression. Clinically, LINC00665 expression was increased but miR-379-5p expression was decreased in breast cancer tissues compared with that in normal breast tissues in the TCGA database. Furthermore, the expression of LINC00665 was negatively related with miR-379-5p expression. Collectively, our results reveal the LINC00665–miR-379-5p–LIN28B axis and shed light on breast cancer therapy.

23 February 2023 in Advanced Science
Verified
Journal Article
Open access
YTYao Tian
Yao Tian
ZCZhao‐Hui Chen
Zhao‐Hui Chen
PWPeng Wu
Peng Wu
DZDi Zhang
Di Zhang
YMYue Ma
Yue Ma
YYYue Yu
Yue Yu
Tamoxifen is commonly used for the treatment of patients with estrogen receptor‐positive (ER+) breast cancer, but the acquired resistance to tamoxifen presents a critical challenge of breast cancer therapeutics. Recently, long noncoding RNA MIR497HG and its embedded miR‐497 and miR‐195 are proved to play significant roles in many types of human cancers, but their roles in tamoxifen‐resistant breast cancer remain unknown. The results indicate that MIR497HG deficiency induces breast cancer progression and tamoxifen resistance by inducing downregulation of miR‐497/195. miR‐497/195 coordinately represses five positive PI3K‐AKT regulators (MAP2K1, AKT3, BCL2, RAF1, and CCND1), resulting in inhibition of PI3K‐AKT signaling, and PI3K‐AKT inhibition in tamoxifen‐resistant cells restored tamoxifen responsiveness. Furthermore, ER α binds the MIR497HG promoter to activate its transcription in an estrogen‐dependent manner. ZEB1 interacts with HDAC1/2 and DNMT3B at the MIR497HG promoter, resulting in promoter hypermethylation and histone deacetylation. The findings reveal that ZEB1‐induced MIR497HG depletion contributes to breast cancer progression and tamoxifen resistance through PI3K‐AKT signaling. MIR497HG can be used as a biomarker for predicting tamoxifen sensitivity in patients with ER+ breast cancer.

1 September 2019 in Molecular Therapy Nucleic Acids
Verified
Journal Article
Open access
JCJiang-Rui Chi
Jiang-Rui Chi
ZYZhi-Hao Yu
Zhi-Hao Yu
BLBo-Wen Liu
Bo-Wen Liu
DZDi Zhang
Di Zhang
JGJie Ge
Jie Ge
XCXu-Chen Cao
Xu-Chen Cao
Breast cancer is the most common malignant tumor and the main cause of cancer-associated mortality in females worldwide. Long non-coding RNAs (lncRNAs) have been reported to play vital roles in breast cancer development and progression; however, our understanding of most lncRNAs in breast cancer is still limited. In this study, we demonstrated that small nucleolar RNA host gene 5 (SNHG5) promotes breast cancer cell proliferation both in vitro and in vivo, and depletion of SNHG5 significantly led to cell-cycle arrest at G1 phase. Accumulating evidence has shown that many lncRNA transcripts could function as competing endogenous RNAs (ceRNAs) by competitively binding common microRNAs (miRNAs). We found that SNHG5 acts as a sponge for miR-154-5p, reducing its ability to repress proliferating cell nuclear antigen (PCNA). SNHG5 promoted breast cancer proliferation and cell-cycle progression by upregulation of PCNA expression. Clinically, we observed an increased SNHG5 expression in breast cancer, whereas miR-154-5p was decreased in breast cancer tissues compared with the adjacent normal breast tissues. Furthermore, the SNHG5 expression was significantly negatively correlated with miR-154-5p expression. Taken together, our data uncover the SNHG5-miR-154-5p-PCNA axis and provide a novel mechanism to explain breast cancer proliferation.

7 October 2015 in Oncotarget
Verified
Journal Article
Open access
PDF file
YYYue Yu
Yue Yu
YZYing Zhao
Ying Zhao
XSXiao-Hu Sun
Xiao-Hu Sun
JGJie Ge
Jie Ge
BZBin Zhang
Bin Zhang
XCXu-Chen Cao
Xu-Chen Cao
Down-regulation of miR-129-5p via the Twist1-Snail feedback loop stimulates the epithelial-mesenchymal transition and is associated with poor prognosis in breast cancer

1 June 2018 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
MWMeng Wang
Meng Wang
WCWen-Run Cai
Wen-Run Cai
RMRan Meng
Ran Meng
JCJiang-Rui Chi
Jiang-Rui Chi
YLYun-Rui Li
Yun-Rui Li
XCXu-Chen Cao
Xu-Chen Cao